NPAT of Cochlear Limited FY 2019-2023
In the financial year 2023, Cochlear Limited had a net profit after tax (NPAT) of approximately 300 million Australian dollars. Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant, and the Baha bone conduction implant.